Cargando…
Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?
OBJECTIVES: To estimate the use of cardiovascular medicines and its distribution by age and sex. DESIGN: Observational study. SETTING: Region of Murcia. MAIN MEASUREMENTS: Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD)...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985612/ https://www.ncbi.nlm.nih.gov/pubmed/24210690 http://dx.doi.org/10.1016/j.aprim.2013.09.003 |
_version_ | 1783491841222508544 |
---|---|
author | Sánchez, Diego P. Guillén, José J. Torres, Alberto M. Sánchez, Fernando I. |
author_facet | Sánchez, Diego P. Guillén, José J. Torres, Alberto M. Sánchez, Fernando I. |
author_sort | Sánchez, Diego P. |
collection | PubMed |
description | OBJECTIVES: To estimate the use of cardiovascular medicines and its distribution by age and sex. DESIGN: Observational study. SETTING: Region of Murcia. MAIN MEASUREMENTS: Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD). A comparison was made of consumption rates (DHD) by age and sex. RESULTS: The probability of receiving antiplatelet drugs increases with age, with the proportion of men being higher. The use of beta-blockers and angiotensin II increases with age up to 79 years, with an increased consumption in men up to 65 years. The probability of receiving treatment with calcium channel blockers, ACE inhibitors, or statins, linearly increases with age, and the proportion of men under treatment exceeds that of women in the early ages, tending to equalize beyond 80 years. CONCLUSIONS: This study shows that the cardiovascular disease prevention focuses on people aged 40 to 74 years. Access by women to cardiovascular therapy occurs with a delay of 3-5 years, depending on the treatment subgroup. Changes should be promoted to encourage rational and equitable access and use of the drugs. |
format | Online Article Text |
id | pubmed-6985612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69856122020-01-30 Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? Sánchez, Diego P. Guillén, José J. Torres, Alberto M. Sánchez, Fernando I. Aten Primaria Originales OBJECTIVES: To estimate the use of cardiovascular medicines and its distribution by age and sex. DESIGN: Observational study. SETTING: Region of Murcia. MAIN MEASUREMENTS: Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD). A comparison was made of consumption rates (DHD) by age and sex. RESULTS: The probability of receiving antiplatelet drugs increases with age, with the proportion of men being higher. The use of beta-blockers and angiotensin II increases with age up to 79 years, with an increased consumption in men up to 65 years. The probability of receiving treatment with calcium channel blockers, ACE inhibitors, or statins, linearly increases with age, and the proportion of men under treatment exceeds that of women in the early ages, tending to equalize beyond 80 years. CONCLUSIONS: This study shows that the cardiovascular disease prevention focuses on people aged 40 to 74 years. Access by women to cardiovascular therapy occurs with a delay of 3-5 years, depending on the treatment subgroup. Changes should be promoted to encourage rational and equitable access and use of the drugs. Elsevier 2014-03 2013-11-06 /pmc/articles/PMC6985612/ /pubmed/24210690 http://dx.doi.org/10.1016/j.aprim.2013.09.003 Text en © 2013 Elsevier España, S.L. Todos los derechos reservados. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Originales Sánchez, Diego P. Guillén, José J. Torres, Alberto M. Sánchez, Fernando I. Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? |
title | Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? |
title_full | Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? |
title_fullStr | Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? |
title_full_unstemmed | Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? |
title_short | Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género? |
title_sort | análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la región de murcia: ¿existen diferencias de género? |
topic | Originales |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985612/ https://www.ncbi.nlm.nih.gov/pubmed/24210690 http://dx.doi.org/10.1016/j.aprim.2013.09.003 |
work_keys_str_mv | AT sanchezdiegop analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero AT guillenjosej analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero AT torresalbertom analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero AT sanchezfernandoi analisisdeladispensaciondemedicamentosparaelcontroldelosprincipalesfactoresderiesgocardiovascularenlaregiondemurciaexistendiferenciasdegenero |